Could obesity drugs ease anxiety and depression?
GLP-1 medications are associated with a reduced need for psychiatric hospital care and fewer employee sick days. They also appear to lower the risk of substance use disorders…. read more.
GLP-1 medications are associated with a reduced need for psychiatric hospital care and fewer employee sick days. They also appear to lower the risk of substance use disorders…. read more.
In an effort to increase access to evidence-based interventions to help manage anxiety and depression, Mass General Brigham investigators have developed and tested a novel digital intervention called HabitWorks. HabitWorks… read more.
A new study reveals that family caregivers of Alzheimer’s patients in Oman face significant unmet needs, ranging from limited knowledge about the disease to high psychological stress and… read more.
Families are feeling stressed, powerless and ‘forever in limbo’ as they wait months, or sometimes years, for Attention-Deficit Hyperactivity Disorder (ADHD) assessments, according to a new study. Research led by the University of Southampton and King’s College London examined… read more.
Burnout is at an all-time high, with some studies saying two-thirds of employees now cite job burnout as a major challenge[1]. Overwork and chronic stress do not just… read more.
A new University of Missouri study suggests mental health policies can play a significant role in how Americans choose political candidates. Past scholarly research has found that most… read more.
A landmark Lancet Psychiatry paper published today – the largest-ever review of the safety and efficacy of cannabinoids across a range of mental health conditions – found no evidence that medicinal cannabis is… read more.
GLP-1 medications, which are used to treat diabetes and obesity, appear to be associated with reduced hospital care and sickness absence from work for psychiatric reasons, researchers reported… read more.
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has found that excessive smartphone use is closely associated with disordered eating, including uncontrolled eating and emotional overeating, as… read more.
Experts are warning that far from being over diagnosed, people with ADHD are waiting too long for assessment, support and treatment. In a paper, published today in the British… read more.
Canadian researchers report that new stimulant prescriptions to treat ADHD among adults have more than doubled since the start of the COVID-19 pandemic. And this finding was especially… read more.
The EMA has recommended the refusal of the marketing authorisation for Iloperidone Vanda Pharmaceuticals, a medicine intended for the treatment of schizophrenia and manic or mixed episodes associated… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.